Symbol="DBVT"
AssetType="Common Stock"
Name="DBV Technologies"
Description="DBV Technologies SA, a clinical-stage biopharmaceutical company, is dedicated to the research and development of epicutaneous immunotherapy products. The company is headquartered in Montrouge, France."
CIK="1613780"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="177-181 AVENUE PIERRE BROSSOLETTE, MONTROUGE, FR"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="337966000"
EBITDA="-86667504"
PERatio="None"
PEGRatio="0"
BookValue="0.953"
DividendPerShare="0"
DividendYield="0"
EPS="-0.56"
RevenuePerShareTTM="0.026"
ProfitMargin="0"
OperatingMarginTTM="-22.49"
ReturnOnAssetsTTM="-0.36"
ReturnOnEquityTTM="-0.767"
RevenueTTM="4492000"
GrossProfitTTM="4844000"
DilutedEPSTTM="-0.56"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.138"
AnalystTargetPrice="5.18"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="28.15"
PriceToBookRatio="1.356"
EVToRevenue="-"
EVToEBITDA="-0.989"
Beta="1.176"
num_52WeekHigh="2.78"
num_52WeekLow="1.08"
num_50DayMovingAverage="1.885"
num_200DayMovingAverage="1.601"
SharesOutstanding="188095000"
DividendDate="None"
ExDividendDate="None"
symbol="DBVT"
open="1.79"
high="1.79"
low="1.70"
price="1.72"
volume="191201.00"
latest_trading_day="2023-07-14"
previous_close="1.79"
change="-0.07"
change_percent="-3.9106%"
aroon_positive_momentum_days="100"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="100"
Volume_recent_avg="115308"
Change_recent_avg="-0.01"
Delta_recent_avg="0.1"
Variance_recent_avg="0.05"
Change_ratio_recent_avg="-0.69"
RSI_change="FALSE"
ADX_change="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="100"
Aroon_momentum_negative="0"
image_negative_thumbnail_id_1="1106"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0139.jpeg"
image_negative_thumbnail_id_2="491"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0114.jpeg"
image_neutral_thumbnail_id_1="563"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0036.jpeg"
image_neutral_thumbnail_id_2="562"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0037.jpeg"
image_positive_thumbnail_id_1="993"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0155.jpeg"
image_positive_thumbnail_id_2="674"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0034.jpeg"
image_professor_thumbnail_id_1="1194"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0028.jpeg"
image_professor_thumbnail_id_2="1178"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0012.jpeg"
